These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22987244)

  • 1. Interaction of serum ferritin and body mass index in patients with chronic hepatitis B: improved prediction of cirrhosis.
    Paul S; O'Regan K; St John A; Stuart K; Crawford D
    Hepatology; 2013 May; 57(5):2094-5. PubMed ID: 22987244
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 21953442.
    Kowdley KV; Nelson J
    Hepatology; 2013 May; 57(5):2095. PubMed ID: 22987775
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P; Kalambokis G; Grillo F; Watkins J; Xirouchakis E; Pleguezuelo M; Leandro G; Arvaniti V; Germani G; Patch D; Calvaruso V; Mikhailidis DP; Dhillon AP; Burroughs AK
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease.
    Chandok N; Minuk G; Wengiel M; Uhanova J
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):53-8. PubMed ID: 22457860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of nonalcoholic fatty liver disease.
    Yanai H; Morimoto M
    JAMA; 2003 Sep; 290(12):1577; author reply 1578. PubMed ID: 14506111
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description.
    Büyükaşik NS; Nadır I; Akin FE; Cakal B; Kav T; Ersoy O; Büyükaşik Y
    Turk J Gastroenterol; 2011 Dec; 22(6):606-11. PubMed ID: 22287406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
    Huang CW; Bai L; Cai JJ; Guo W; Lan L
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.
    Mao W; Hu Y; Lou Y; Chen Y; Zhang J
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):130-6. PubMed ID: 25419642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
    Yoneda M; Mawatari H; Fujita K; Iida H; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
    J Gastroenterol; 2007 Jul; 42(7):573-82. PubMed ID: 17653654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection.
    Amanzada A; Goralczyk AD; Moriconi F; van Thiel DH; Ramadori G; Mihm S
    J Med Virol; 2013 Sep; 85(9):1534-41. PubMed ID: 23852677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute alcoholic hepatitis (fatty liver hepatitis)].
    Sohnack H
    Wien Med Wochenschr; 1972 Jul; 122(30):460-4. PubMed ID: 5065650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adiponectin and chronic viral hepatitis].
    Yin HZ; Cao ZC
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):955-7. PubMed ID: 20038346
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver guide for monitoring of chronic hepatitis C.
    Hedin K; Babic A; Frydén A
    Proc AMIA Symp; 2000; ():340-3. PubMed ID: 11079901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour of antithrombin 3 in liver disease.
    Duckert F
    Scand J Gastroenterol Suppl; 1973; 19():109-12. PubMed ID: 4515632
    [No Abstract]   [Full Text] [Related]  

  • 20. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
    Hashimoto E; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.